Avantor (AVTR) Other Non-Current Assets (2018 - 2026)
Avantor (AVTR) posted quarterly Other Non-Current Assets of $412.0 million for Q2 2026, up 5.4% year-over-year from $390.9 million in Q2 2025, and down 6.72% quarter-over-quarter from $441.7 million in Q1 2026.
Avantor (AVTR) Other Non-Current Assets (2018 - 2026) Analysis & Trends
Avantor's Other Non-Current Assets history runs 9 years deep, the most recent figure standing at $412.0 million for Q2 2026.
- In Q2 2026, Other Non-Current Assets rose 5.4% year-over-year to $412.0 million; the TTM figure through Jun 2026 stood at $412.0 million (up 5.4% YoY), while the FY2025 annual figure was $396.0 million, up 9.88% from the prior year.
- Other Non-Current Assets for Q2 2026 stood at $412.0 million, down from $441.7 million in the prior quarter.
- The five-year high for Other Non-Current Assets was $441.7 million in Q1 2026, with the low at $244.6 million in Q3 2022.
- The 5-year median for Other Non-Current Assets is $364.0 million (2024), against an average of $342.9 million.
- The sharpest annual moves came in 2024 and 2025: Other Non-Current Assets soared 45.16% in 2024, then decreased 3.36% in 2025.
- Avantor's Other Non-Current Assets stood at $293.5 million in 2022, then rose by 22.08% to $358.3 million in 2023, then gained by 0.59% to $360.4 million in 2024, then increased by 9.88% to $396.0 million in 2025, then climbed by 4.04% to $412.0 million in 2026.
- Business Quant data shows AVTR's Other Non-Current Assets at $412.0 million in Q2 2026, $441.7 million in Q1 2026, and $396.0 million in Q4 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Other Non-Current Assets (Qtr) |
|---|---|---|---|---|---|
| 1 | Intuitive Surgical | 134.13 Bn | 128.91 Bn | 1.96 Bn | - |
| 2 | Becton Dickinson | 52.76 Bn | 51.90 Bn | 2.32 Bn | 2.55 Bn |
| 3 | Alcon | 35.81 Bn | 34.46 Bn | 1.68 Bn | 434.00 Mn |
| 4 | Resmed | 33.72 Bn | 32.25 Bn | 861.22 Mn | 457.39 Mn |
| 5 | Medline | 29.38 Bn | 26.70 Bn | 2.22 Bn | 22.91 Bn |
| 6 | West Pharmaceutical Services | 25.00 Bn | 24.57 Bn | 329.20 Mn | 82.80 Mn |
| 7 | Solventum | 15.46 Bn | 15.06 Bn | 1.29 Bn | 904.00 Mn |
| 8 | Cooper Companies | 14.88 Bn | 14.74 Bn | 735.40 Mn | 672.80 Mn |
| 9 | Baxter International | 13.58 Bn | 11.43 Bn | 1.03 Bn | 669.00 Mn |
| 10 | Avantor | 9.76 Bn | 9.45 Bn | 537.00 Mn | 412.00 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 412.00 Mn |
| Mar 31, 2026 | 441.70 Mn |
| Dec 31, 2025 | 396.00 Mn |
| Sep 30, 2025 | 405.70 Mn |
| Jun 30, 2025 | 390.90 Mn |
| Mar 31, 2025 | 367.50 Mn |
| Dec 31, 2024 | 360.40 Mn |
| Sep 30, 2024 | 419.80 Mn |
| Jun 30, 2024 | 368.10 Mn |
| Mar 31, 2024 | 367.70 Mn |
| Dec 31, 2023 | 358.30 Mn |
| Sep 30, 2023 | 289.20 Mn |
| Jun 30, 2023 | 276.70 Mn |
| Mar 31, 2023 | 272.50 Mn |
| Dec 31, 2022 | 293.50 Mn |
| Sep 30, 2022 | 244.60 Mn |
| Jun 30, 2022 | 254.80 Mn |
| Mar 31, 2022 | 252.00 Mn |
| Dec 31, 2021 | 233.10 Mn |
| Sep 30, 2021 | 240.00 Mn |